Stockscreener 앱 받기
2.47
7.39%
0.17
전일 마감가:
$2.30
열려 있는:
$2.29
하루 거래량:
317.09K
Relative Volume:
0.65
시가총액:
$157.30M
수익:
-
순이익/손실:
$-30.92M
주가수익비율:
-4.0969
EPS:
-0.6029
순현금흐름:
$-27.39M
1주 성능:
+15.96%
1개월 성능:
+3.78%
6개월 성능:
+85.71%
1년 성능:
-10.51%
1일 변동 폭
$2.22
$2.49
1주일 범위
$2.115
$2.58
52주 변동 폭
$0.41
$3.43
Tuhura Biosciences Inc Stock (HURA) Company Profile
명칭
Tuhura Biosciences Inc
전화
813-875-6600
주소
10500 UNIVERSITY CENTER DR., TAMPA
Compare HURA vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HURA
Tuhura Biosciences Inc
|
2.47 | 149.02M | 0 | -30.92M | -27.39M | -0.6029 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-27 | 개시 | Citizens | Mkt Outperform |
| 2025-03-03 | 개시 | H.C. Wainwright | Buy |
| 2024-12-19 | 개시 | Rodman & Renshaw | Buy |
| 2024-11-05 | 개시 | Maxim Group | Buy |
Tuhura Biosciences Inc 주식(HURA)의 최신 뉴스
TuHURA Biosciences (NASDAQ:HURA) Posts Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
TuHURA Biosciences Highlights Phase III IFx Push, AML Trial Plans at Canaccord - MarketBeat
TuHURA Biosciences, Inc.Common Stock (HURA) Stock Price, News, Quote & History - FinancialContent
TuHURA Biosciences Q2 Results: EPS beats estimate, losses narrow 33% YoY - scanx.trade
TuHURA Secures $50M Credit Facility Extending Cash Runway into 2028 - Minichart
Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update - TradingView
Form 8K TuHURA Biosciences Inc For: 14 August By Investing.com - Investing.com Canada
TuHURA Reports $1.0 Million Cash and Advances TBS-2025 AML Program - quiverquant.com
TuHURA Bios reports Q2 2026: $1.0M cash, R&D $6.6M, $50M credit facility extends runway - TradingView
TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update - PR Newswire
TuHURA Biosciences Expands Use of Revolving Credit Facility - TipRanks
TuHURA at canaccord growth conference: late-stage push gains traction By Investing.com - Investing.com Nigeria
TuHURA at canaccord growth conference: late-stage push gains traction - Investing.com
Enterprise value to EBIT forward of TuHURA Biosciences, Inc. – NASDAQ:HURA - TradingView
HURA Q2'26 Earnings: revenue estimate is 0 USD - TradingView
TuHURA Biosciences (HURA) Expected to Release Quarterly Earnings on Thursday - MarketBeat
TuHURA Biosciences (HURA) Dips 5.9% as Stock Tests Key Support Near $2.00Ichimoku TK Cross - dars.gov.et
TuHURA Biosciences Inc (HURA) Cash Flow - TradingKey
TuHURA Biosciences Inc (HURA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TuHURA Biosciences Inc (HURA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TuHURA Biosciences Inc (HURA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
HURA|TuHURA Biosciences Inc|Price:2.110|Chg%:-0.040 - TradingKey
TradingKey - TradingKey
HURA|TuHURA Biosciences Inc|Price:2.210|Chg%:+0.100 - TradingKey
TuHURA Biosciences, Inc. (NASDAQ:HURA) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
HURA Stock Price, Quote & Chart - ChartMill
TuHURA Biosciences to Present at Canaccord Genuity Conference - Intellectia AI
TuHURA CEO to present at Canaccord Genuity Grow... - Pluang
TuHURA Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference - PR Newswire
TuHURA Biosciences (NASDAQ:HURA) Stock Price Down 1.3%Time to Sell? - MarketBeat
TuHURA Biosciences (HURA) Proxy filing Summary - Quartr
TuHURA Biosciences (HURA) Registration filing Summary - Quartr
TuHURA Biosciences Inc. (HURA) Q1 2026 Earnings: EPS Miss and Pre-Revenue ChallengesConsensus Beat Rate - dars.gov.et
Form DEF 14A TuHURA Biosciences For: 9 July By Investing.com - Investing.com Nigeria
TuHURA Biosciences (HURA) Stock Forum and Discussion - Moomoo
TuHURA Biosciences, Inc. (NASDAQ: HURA) Files 8-K Report Detailing Company Information and Compliance Updates – Minichart - Minichart
TuHURA Biosciences names Amanda Garofalo as clinical operations SVP - Investing.com
TuHURA Biosciences, Inc.(NasdaqCM: HURA) dropped from Russell 2000 Dynamic Index - marketscreener.com
TuHURA Biosciences, Inc.(NasdaqCM: HURA) dropped from Russell 3000E Index - marketscreener.com
TuHURA Biosciences, Inc.(NasdaqCM:HURA) dropped from Russell Small Cap Completeness Index - marketscreener.com
TuHURA Biosciences, Inc.(NasdaqCM: HURA) dropped from Russell 2500 Index - marketscreener.com
Enterprise value to EBIT forward of TuHURA Biosciences, Inc. – FWB:PL3 - TradingView
TuHURA Biosciences, Inc.(NasdaqCM: HURA) dropped from Russell 3000 Index - marketscreener.com
TuHURA Biosciences, Inc.(NasdaqCM: HURA) dropped from Russell 2000 Index - marketscreener.com
TuHURA Biosciences, Inc.(NasdaqCM:HURA) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
TuHURA Biosciences, Inc.(NasdaqCM:HURA) dropped from Russell 3000 Growth Benchmark - marketscreener.com
TuHURA Biosciences, Inc.(NasdaqCM:HURA) dropped from Russell 2000 Growth Benchmark - marketscreener.com
TuHURA Biosciences, Inc.(NasdaqCM:HURA) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Enterprise value to EBITDA forward of TuHURA Biosciences, Inc. – NASDAQ:HURA - TradingView
EBITDA per share of TuHURA Biosciences, Inc. – DUS:PL3 - TradingView
Price to earnings forward of TuHURA Biosciences, Inc. – DUS:PL3 - TradingView
Tuhura Biosciences Inc (HURA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.07%
자본화:
|
볼륨(24시간):